Immunology Laboratories, Inc. (Immlab) is a leading research-based company in Birmingham, AL, specializing in the development of stable, tested, and effective staphylococcal vaccines for humans and animals. With over 40 years of research and patented technology, Immlab offers innovative solutions to prevent and treat staphylococcal infections, including those caused by emerging and antibiotic-resistant bacterial strains.
Using their unique approach of introducing the genome of the staphylococcal bacteriophage into the staphylococcal cell, Immlab's vaccines stimulate multiple immune responses, providing both innate and adaptive immunity. Their product line of staphylococcal-lysate-based vaccines not only improves the health and well-being of individuals and animals, but also addresses the growing concern of antibiotic resistance. With the ability to adapt to changing epidemiological situations, Immlab's vaccines offer a promising solution in the fight against staphylococcal infections.
Generated from the website